- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03116815
The Feasibility of a Web-based Application to Monitor Home Blood Pressure
March 4, 2020 updated by: Holly J. Mattix-Kramer, Loyola University
Control of hypertension remains one of the most important interventions available to clinicians to reduce risk of cardiovascular disease, kidney disease and stroke.
Self-measured home blood pressure monitoring plus additional support has been shown to reduce blood pressure in adults with previously uncontrolled hypertension.
Most previous studies have utilized healthcare personnel to facilitate communication of home blood pressure levels to physicians and did not provide methods to directly transmit self-measured blood home blood pressure levels to physicians via the electronic health record.
Emerging technology now provides the ability for patient's to upload self-measured blood pressure levels into their own medical record which may eliminate the need for additional health personnel.
This study will examine the feasibility, patient adherence and physician and patient perceptions of a web-based application which will facilitate direct input of self-measured home blood pressure levels and patient reported symptoms directly into the electronic health record with message alerts to the provider for hypertension management.
Up to 10 Loyola primary care physicians and 20 of their respective patients age 50 years and older who have a smart phone device or home computer and have treated hypertension will be enrolled.
The study will utilize the existing web-application called MyChart.
MyChart is the name of the web-based application and it is not an acronym.
Enrolled patients will download the existing MyChart web-based application on their smart phone device or home computer and will record home blood pressure measurements using their home blood pressure machine into their smart phone application.
The MyChart application is available to all patients receiving care in the Loyola Health Care System.
The blood pressure readings and patient reported symptoms will then be available for their physicians to review within the electronic health record.
After using the web-based application for two months, both patients and physicians will be asked to participate in focus groups and interviews, respectively, to determine their perceptions and satisfaction with the web-based application.
Data from this feasibility study may be used to guide a future clinical trial of hypertension management that examines the effectiveness of the MyChart web-based application for frequent blood pressure monitoring compared to standard care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Observational studies and clinical trials have demonstrated that clinicians fail to intensify therapy in hypertensive management despite patients not meeting goal.
For this reason, patient centered tools can help facilitate meeting goals with the provider.
Web-based communication combined with provider care management successfully lowered blood pressure to <140/90 mm Hg in prior studies of patients with hypertension.
Emerging technology now provides the ability for patients to upload self-measured home blood pressure information into their own medical record which may eliminate the need for additional health personnel.
This study will investigate the feasibility of health informatics to facilitate better compliance and safety for both provider and patient for hypertension management.
The home blood pressure readings along with patient reported symptoms will be recorded using the MyChart, a web-based tool available to all patients receiving care at Loyola University Medical Center.
MyChart can be accessed with a hand-held device or home computer.
After enrollment, patients will receive a notice every two weeks via MyChart to upload home blood pressure values and patient reported symptoms.
This information entered into MyChart by patients will be placed into the electronic health record in a home vital signs flow sheet, which will be separate from the flow sheet of vital signs measured in the clinic.
Physicians will receive an alert message when patients upload the blood pressure data.
The alert message will provide physicians with the average blood pressure value over the two weeks and will provide simple guidance on whether actions, such as titrating existing medication should be taken (based on whether BP is ≥ 140/90 mmHg).
Patients will also be able to track their own home blood pressure values using the MyChart application.
As a first step, we are first examining the feasibility of this web-based application and determining the perceptions of both patients and physicians.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Maywood, Illinois, United States, 60153
- Loyola University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Willing to participate in all study procedures
- Potential subject owns a personal device and is able to run the web-application
- Physician directed blood pressure goal is < 140/90 mmHg
Exclusion Criteria:
- No use of blood pressure lowering medications
- Arm circumference too large or small to allow accurate blood pressure measurement
- A medical condition likely to limit survival to less than 6 months, or a cancer diagnosed and treated within the past two years that, in the judgment of clinical study staff, would compromise a participant's ability to complete the study
- Inability to give informed consent
- History of systolic heart failure (ejection fraction < 35%)
- History of stroke
- History of proteinuria ≥ 1 gram in a 24 hour urine collection or a random urine albumin/creatinine ratio ≥ 300 mg/g or a random urine protein/creatinine ratio ≥ 300 mg/g
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Intervention
Intervention is the use of the MyChart web-application whereby participants record their home blood pressure readings directly into their electronic medical record.
Their physicians are then alerted of these blood pressure readings.
|
Participants will record home blood pressure readings directly into the electronic health record via the MyChart application
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The total number of patients screened for the study
Time Frame: 30 days
|
The total number of patients who were examined for study eligibility
|
30 days
|
|
The total number of patients who meet study eligibility
Time Frame: 30 days
|
The total number of patients who are screened for the study and meet study eligibility
|
30 days
|
|
The total number of patients who provide written informed consent to participate in the study
Time Frame: 30 days
|
The total number of patients who enroll in the study and provide written informed consent
|
30 days
|
|
The number of home blood pressure readings submitted by patients to the MyChart web-based application
Time Frame: 60 days
|
The actual number of home blood pressure readings that are recorded in the electronic health record as submitted via MyChart
|
60 days
|
|
Change in systolic blood pressure
Time Frame: 60 days
|
Change in systolic blood pressure
|
60 days
|
|
Change in diastolic blood pressure
Time Frame: 60 days
|
Change in diastolic blood pressure
|
60 days
|
|
Physician actions based on home blood pressure readings
Time Frame: 60 days
|
Total number of times a physician escalates or de-escalates blood pressure lowering medications for a study participant
|
60 days
|
|
Correlation between office and home blood pressure readings
Time Frame: one day
|
Correlation between the office blood pressure measurement using the clinic Omron machine and the patient's home blood pressure cuff
|
one day
|
|
Adverse events
Time Frame: 60 days
|
Total number of patient reported adverse events and all hospitalizations and emergency room visits
|
60 days
|
|
Patient reported outcomes
Time Frame: 60 days
|
The percentage quality of life questionnaires completed by the study participants
|
60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Holly Kramer, MD MPH, Loyola University Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 16, 2017
Primary Completion (Actual)
October 1, 2019
Study Completion (Actual)
October 1, 2019
Study Registration Dates
First Submitted
April 11, 2017
First Submitted That Met QC Criteria
April 14, 2017
First Posted (Actual)
April 17, 2017
Study Record Updates
Last Update Posted (Actual)
March 6, 2020
Last Update Submitted That Met QC Criteria
March 4, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 209116
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Direct input of home blood pressure readings via MyChart
-
Duke-NUS Graduate Medical SchoolSingHealth PolyclinicsUnknown
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationHypertension (HTN)United States
-
Queen's UniversityHeart and Stroke Foundation of OntarioCompleted
-
Stanford UniversityRecruitingVascular Diseases | Stroke | Hypertension | TIAUnited States
-
Accumbo ABUniversity Hospital, LinkoepingCompleted
-
University of California, San FranciscoCompletedPortal Hypertension | Cirrhosis, Liver | Ascites HepaticUnited States
-
University of LeicesterUniversity Hospitals, Leicester; Freemasons' Medical Research FundingCompletedPost Myocardial InfarctionUnited Kingdom
-
Rockefeller UniversityClinical Directors Network; Carter Burden NetworkCompleted
-
University College DublinSt Vincent's University Hospital, Ireland; National University of Ireland,... and other collaboratorsRecruitingIschemic Stroke | Transient Ischemic AttackIreland
-
Hoffmann-La RocheCompletedCoronary Heart DiseaseNetherlands, United States, United Kingdom, Czechia